Prevalence of SARS-CoV-2 antibodies among Swiss hospital workers: Results of a prospective cohort study

Infect Control Hosp Epidemiol. 2021 May;42(5):604-608. doi: 10.1017/ice.2020.1244. Epub 2020 Oct 8.

Abstract

In this prospective cohort of 1,012 Swiss hospital employees, 3 different assays were used to screen serum for SARS-CoV-2 antibodies. Seropositivity was 1%; the positive predictive values of the lateral-flow immunoassay were 64% (IgG) and 13% (IgM). History of fever and myalgia most effectively differentiated seropositive and seronegative participants.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Antibodies, Viral / blood*
  • COVID-19 / blood
  • COVID-19 / diagnosis*
  • COVID-19 / virology
  • Female
  • Humans
  • Immunoassay
  • Immunoglobulin G / blood*
  • Immunoglobulin M / blood*
  • Male
  • Middle Aged
  • Personnel, Hospital / statistics & numerical data*
  • Prevalence
  • Prospective Studies
  • SARS-CoV-2
  • Seroepidemiologic Studies
  • Switzerland / epidemiology
  • Young Adult

Substances

  • Antibodies, Viral
  • Immunoglobulin G
  • Immunoglobulin M